AzTrials
AzTrials

Alcohol Use DisorderCoSMANCT06985927

Self-Concept and Autobiographical Memory in Alcohol Use Disorder

A study testing psychotherapeutic sessions in people with Alcohol Use Disorder, run by CHU de Reims at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study has two objectives. First, to evaluate the effectiveness of psychotherapy sessions based on self-concept and autobiographical memory in patients suffering from alcohol use disorders (AUD). Second, investigate the relationship between drinking identity and AUD. Read more about this study

Who is it for?
Ages 24 years and older
Conditions the study is for
Alcohol Use Disorder
What is being tested?
psychotherapeutic sessions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteFrance
Study dates
28 May 2025to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients over 24 years old, men or women
  • Having a diagnosis of alcohol use disorder according to DSM-5 criteria
  • Being a native French speaker
  • Patients enrolled in the national healthcare insurance program
  • Consenting to participate to the study

Who cannot join

  • A diagnosis of current non-stabilized psychiatric disorders according to DSM-5 criteria
  • The presence of another substance use disorder, except for tobacco dependence
  • The presence of any intellectual disability, of pervasive developmental disorders
  • The presence of any neurological disorder or any other disorder affecting the central nervous system including neurological complications of alcoholism
  • A sensorial impairment uncorrected (visual and/or hearing)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Chu Reims

    Reims, 51092

    Damien JOLLY, 326788472 ext. 33, djolly@chu-reims.fr

    Recruiting

Other trials in France

About this study

Official title: Self-Concept and Autobiographical Memory in the Care of Patients With Alcohol Use Disorder

This study has two objectives. First, to evaluate the effectiveness of psychotherapy sessions based on self-concept and autobiographical memory in patients suffering from alcohol use disorders (AUD). Second, investigate the relationship between drinking identity and AUD. These objectives will be investigated according to a longitudinal design.

In this study, the drinking identity is evaluated on its implicit dimension and on its explicit dimension. Levels of alcohol use and dependence are assessed by the amount and frequency of drinking, the duration of abstinence, and the intensity of AUD symptoms. These assessments consist three visits: on the day of inclusion, then at three months and six months after the first visit. The psychotherapy sessions consist of four individual sessions. They are inspired by the Social Identity Mapping in Addiction Recovery (SIM-AR) by Beckwith et al. (2019), combined with autobiographical reasoning exercises.

Read more

Patients with an AUD, participants in the study, are recruited from the addiction department of the Etablissement Public de Santé Mentale de la Marne. To investigate the effects of individual psychotherapy sessions, two groups of patients are constituted randomly. The first group will have four psychotherapy sessions between the first visit and the second vist. The second group will not follow psychotherapy sessions but will benefit from the usual addiction treatments.

The first hypothesis is that patients who have completed the psychotherapy sessions will have lower alcohol consumption (frequency, quantities, peaks) and symptoms of AUD (cravings, drinking refusal self-efficacy and feeling of recovery) than those who have not benefited from the program.

The second hypothesis is that implicit and explicit levels of drinking identity will predict alcohol consumption (frequencies, quantities, peaks) and symptoms of dependence (cravings, drinking refusal self-efficacy and feeling of recovery) for all participants.

Read the detailed description

BACKGROUND Surveys on the proportion of deaths attributable to alcohol consumption consider this practice to be the second cause of avoidable mortality in France. The first victims of alcohol consumption are patients with Alcohol Use Disorder (AUD). This chronic and complex pathology requires treatment that takes into account many factors of biological, psychological and social origin. From this perspective, one of the factors highlighted in the understanding of drinking behavior is the drinking identity. Drinking identity is the integration, more or less conscious, of alcohol as part of one's self-concept. It works in two dimensions, based on the dual-process model of Strack and Deutsch: an implicit dimension and an explicit dimension. A recent meta-analysis showed that, in the general population, the drinking identity is a robust predictor of drinking behaviors and the problems associated. Thus, the drinking identity appears to be a particularly relevant field of research and intervention within the framework of the AUD. To help patients with AUD to change their drinking identity, this study proposes to evaluate the interest of psychotherapeutic workshops focused on Autobiographical Memory (AM) and self-concept. This form of memory stores all of an individual's autobiographical information and memories. AM has the elements that help individuals to build a coherent image of themselves and to update their self-concept. Thus, AM could be a therapeutic lever towards drinking identity.

STUDY PROCEDURES This longitudinal study has two aims. Firs aims is to analyze the therapeutic effectiveness of psychotherapy sessions based on self-concept and AM for patients with alcohol use disorder. Indeed, the management of AUD has a moderate effectiveness. The search for new tools and therapeutic axes is crucial. The link between drinking identity and alcohol consumption was observed only in a general population, so, the second aim of this study is to observe in people with AUD, the link between the level of drinking identity, alcohol consumption and the level of alcohol dependence.

Plan: 60 patients with AUD will be recruited within the addiction unit of the Etablissement Public de Santé Mentale de la Marne (France). In order to investigate the effects of psychotherapeutic sessions and the relationship between the drinking identity and AUD. This study will follow a longitudinal model. All sixty participants will have three evaluation times (visits): a first evaluation and inclusion visit, a second evaluation visit 3 months later and a third evaluation visit 6 months after the first visit. During these visits, the levels of alcohol consumption and symptoms of dependence are assessed as well as the level of drinking identity.

In addition, to observe the effects of individual psychotherapy sessions, two groups of patients will be constituted randomly (each group is composed of 30 participants). The first group will carries out four psychotherapeutic sessions focused on AM and the self-concept.

Measures For the assessment of alcohol consumption and AUD, several measures are used. For alcohol consumption, the frequency, quantities and peaks of consumption are recorded. For AUD, several dimensions are evaluated: cravings, drinking refusal self-efficacy and feeling of recovery.

Explicit drinking identity is the identity integration of alcohol accessible to consciousness giving during introspection: "Alcohol is part of who I am". Conversely, implicit drinking identity is an unconscious and rapid cognitive process forming one of the elements of the network constituting the "self". And whose link between the self and this representation would be more or less important. The evaluation of the explicit drinking identity will be made through self-questionnaires. Conversely, the implicit drinking identity will be evaluated with computer task: implicit association test.

Finally, other measures are carried out, in particular to observe the link between drinking identity and AM as well as the effect of psychotherapeutic workshops such as: self-defining memory task or self-esteem.

Hypotheses:

The first hypothesis is that patients who will have completed the psychotherapy sessions will have lower alcohol consumption (frequency, quantities, peaks) and lower symptoms of AUD (cravings, drinking refusal self-efficacy and feeling of recovery) than those who have not benefited from the program.

The second hypothesis is that implicit and explicit levels of drinking identity will predict alcohol consumption (frequencies, quantities, peaks) and symptoms of dependence (cravings, drinking refusal self-efficacy and feeling of recovery) for all participants.

Being tested
psychotherapeutic sessions
Keywords
Alcohol Use Disorders, Self-Concept, Autobiographical Memory, Psychotherapeutic Care
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • psychotherapeutic sessionsBehavioural

    Analysis of effect of psychotherapeutic sessions based on self-concept and autobiographical memory on alcohol addiction

Study groups in NCT06985927
Study groupRoleWhat they receive
Control GroupNo interventionNot described
Self-Concept GroupExperimentalNot described
Receives: Behavioral: psychotherapeutic sessions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Severity of alcohol use disorder

    The Alcohol Use Disorder Inventory Test (AUDIT). The AUDIT is self-administered questionnaire consists of 10 items designed to identify the risk of the presence of an alcohol use disorder with or without dependence. Items 1 to 6 assess the presence of an alcohol use disorder, and items 7 to 10 assess problems associated with the participant's drinking pattern

    Measured: Day 0, to 3 months, to 6 months

Secondary outcomes (2)
  1. Craving

    Evaluated through Obsessive Compulsive Drinking Scale (OCDS). The OCDS is 12-item self-questionnaire assesses obsessive thoughts and compulsive cravings for alcohol

    Measured: Day 0, to 3 months, to 6 months

  2. Drinking refusal self-efficacy

    Drinking Refusal Self-Efficacy Questionnaire-Revised (DRSEQ-R) It consists of 19 items in the form of first-person statements, positioned on a 6-point Likert scale. It assesses participants' beliefs about their ability to resist drinking in certain situations on three dimensions: social pressure, emotional relief and opportunistic drinking

    Measured: Day 0, to 3 months, to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2025
  2. Study start28 May 2025
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
participants are assigned to one of two or more groups in parallel for the duration of the study
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06985927
Sponsor's protocol ID
PO25057*
Acronym
CoSMA
Status last verified
Aug 2026
First submitted
15 May 2025
Last updated
5 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing psychotherapeutic sessions in people with Alcohol Use Disorder, run by CHU de Reims at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Farid BENZEROUK (03 26 61 19 30 ext. 0033, benzeroukf@epsm-marne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Severity of alcohol use disorder (time frame: Day 0, to 3 months, to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in